Uro-Oncology Medical Science Liaison

Role: Medical Science Liaison Contract type: Permanent / Full Time Area to cover: Emilia-Romagna, Marche,

Revolution Medicines in Italy seeks a Medical Science Liaison who will build and maintain relationships with KOLs, healthcare professionals and academic centers to advance scientific and medical knowledge while representing the company’s oncology portfolio.You will engage in peer-to-peer scientific dialogue, support clinical studies in the territory,...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Alfasigma is a privately held global healthcare company founded over 75 years ago in Italy, where it remains headquartered today in Bologna and Milan. The Group operates in over 100 markets spanning Europe, North and South America, Asia, and Africa. Over three years ago, we embarked on a transformative journey to become a truly global innovative healthcare...

Field-based Medical Science Liaison in Oncology providing scientific support, education, and patient recruitment assistance to clinical trial sites across Italy,

Medical Science Liaison Pediatric Oncology - Italy Want a 3D Career? Join Norgine. At Norgine, our colleagues Dare themselves to be different and try new things, Drive to achieve their goals and beyond, and Develop themselves and their community. We call it the 3D career at Norgine and it offers you a fully‑rounded experience with no limits. Bring...

Quetzal Therapeutics seeks an experienced contractor Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology trial across Italy and Germany. The role emphasizes scientific engagement with investigators, trial awareness, and compliant exchange within regulatory and SOP frameworks.The candidate will operate across a distributed...

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri‑complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...